ATE69891T1 - Monoklonalantikoerperabfassung fuer diagnostischen gebrauch. - Google Patents

Monoklonalantikoerperabfassung fuer diagnostischen gebrauch.

Info

Publication number
ATE69891T1
ATE69891T1 AT84850009T AT84850009T ATE69891T1 AT E69891 T1 ATE69891 T1 AT E69891T1 AT 84850009 T AT84850009 T AT 84850009T AT 84850009 T AT84850009 T AT 84850009T AT E69891 T1 ATE69891 T1 AT E69891T1
Authority
AT
Austria
Prior art keywords
draft
monoclonal antibody
diagnostic use
formulation containing
antigens
Prior art date
Application number
AT84850009T
Other languages
English (en)
Inventor
Karl Arne Lundblad
Original Assignee
Monocarb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20349708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE69891(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Monocarb Ab filed Critical Monocarb Ab
Application granted granted Critical
Publication of ATE69891T1 publication Critical patent/ATE69891T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT84850009T 1983-01-21 1984-01-10 Monoklonalantikoerperabfassung fuer diagnostischen gebrauch. ATE69891T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8300320A SE434680B (sv) 1983-01-21 1983-01-21 Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning
EP84850009A EP0115476B1 (de) 1983-01-21 1984-01-10 Monoklonalantikörperabfassung für diagnostischen Gebrauch

Publications (1)

Publication Number Publication Date
ATE69891T1 true ATE69891T1 (de) 1991-12-15

Family

ID=20349708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84850009T ATE69891T1 (de) 1983-01-21 1984-01-10 Monoklonalantikoerperabfassung fuer diagnostischen gebrauch.

Country Status (6)

Country Link
US (1) US4618486A (de)
EP (1) EP0115476B1 (de)
JP (1) JPH0654316B2 (de)
AT (1) ATE69891T1 (de)
DE (1) DE3485289D1 (de)
SE (1) SE434680B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764465A (en) * 1984-04-26 1988-08-16 Cetus Corporation Human monoclonal antibody against group A red blood cells
EP0223978B1 (de) * 1985-10-11 1992-08-19 Abbott Laboratories Diagnostische Probe
US4695553A (en) * 1985-11-01 1987-09-22 Becton Dickinson And Co., Inc. Method for increasing agglutination of groups of cells to produce improved cell layer interface in centrifuged blood sample using antibodies
US4837170A (en) * 1986-01-20 1989-06-06 Otsuka Pharmaceutical Co., Ltd. Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor
DE3901458A1 (de) * 1989-01-19 1990-07-26 Behringwerke Ag Verwendung von zwei- oder dreiwertigen kationen in immunchemischen tests
DE4035174A1 (de) * 1990-11-06 1992-05-07 Biotest Ag Verfahren zur bestimmung von proteinen in koerperfluessigkeiten und mittel zur durchfuehrung des verfahrens
WO2003009817A2 (en) * 2001-07-25 2003-02-06 Protein Design Labs, Inc. Stable lyophilized pharmaceutical formulation of igg antibodies
WO2004039337A2 (en) * 2002-10-31 2004-05-13 Protein Design Labs, Inc. Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization
EP1660186B1 (de) 2003-08-18 2013-12-25 MedImmune, LLC Humanisierung von antikörpern
WO2005121322A1 (en) * 2004-06-11 2005-12-22 Kiwi Ingenuity Limited Enzymatic modification of cell-surface h antigen by glycosyltransferases
EP1869192B1 (de) 2005-03-18 2016-01-20 MedImmune, LLC Rahmenmischung von antikörpern
AU2006261920A1 (en) 2005-06-23 2007-01-04 Medimmune, Llc Antibody formulations having optimized aggregation and fragmentation profiles
WO2011029823A1 (en) 2009-09-09 2011-03-17 Novartis Ag Monoclonal antibody reactive with cd63 when expressed at the surface of degranulated mast cells
JP2013543384A (ja) 2010-10-05 2013-12-05 ノバルティス アーゲー 抗−ｉｌ１２ｒベータ１抗体ならびに自己免疫性および炎症性疾患の処置おけるその使用
SI2953969T1 (sl) 2013-02-08 2020-01-31 Novartis Ag Protitelesa proti-IL-17A in njihova uporaba v zdravljenju avtoimunskih in vnetnih motenj
US20170291939A1 (en) 2014-06-25 2017-10-12 Novartis Ag Antibodies specific for il-17a fused to hyaluronan binding peptide tags
BR112018014150A2 (en) 2016-01-11 2018-12-11 Novartis Ag immunostimulating humanized monoclonal antibodies to human interleukin-2, and fusion proteins thereof
US11773160B1 (en) 2022-08-05 2023-10-03 Anaveon AG Immune-stimulating IL-2 fusion proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164558A (en) * 1976-11-22 1979-08-14 Massachusetts Institute Of Technology Method for optimizing reagents for agglutination reactions
US4319882A (en) * 1980-02-21 1982-03-16 Yash Sharma Method for detecting immunological agglutination and biochemical agent therefor
WO1982003089A1 (en) * 1981-03-06 1982-09-16 Lennox Edwin Samuel Monoclonal antibody
EP0061541A1 (de) * 1981-03-27 1982-10-06 Biospecia Limited Immunologische Analyse und biochemisches Mittel hierfür
WO1982003462A1 (en) * 1981-03-27 1982-10-14 Ltd Biospecia Immunological analysis and a biochemical agent therefore
GB2117789B (en) * 1982-03-29 1985-08-29 East Anglian Regional Health Abo blood grouping reagent
GB2127434A (en) * 1982-09-17 1984-04-11 Univ London A human monoclonal antibody against Rhesus D antigen

Also Published As

Publication number Publication date
US4618486A (en) 1986-10-21
JPS59138959A (ja) 1984-08-09
EP0115476B1 (de) 1991-11-27
SE8300320L (sv) 1984-07-22
EP0115476A2 (de) 1984-08-08
SE434680B (sv) 1984-08-06
DE3485289D1 (de) 1992-01-09
JPH0654316B2 (ja) 1994-07-20
SE8300320D0 (sv) 1983-01-21
EP0115476A3 (en) 1988-10-12

Similar Documents

Publication Publication Date Title
ATE69891T1 (de) Monoklonalantikoerperabfassung fuer diagnostischen gebrauch.
EP0420913A4 (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
IL76142A0 (en) Monoclonal antibody specific to human carcinoma tumorassociated antigen,hybrid cell lines producing the same and methods for the use thereof
AU498364B2 (en) Assaying antibody, antigen or antibody-antigen complex in fluid sample
ES2124209T3 (es) Anticuerpos monoclonales mejorados reactivos con caquectina.
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
GB2185266B (en) Monoclonal antibodies cross-reactive and cross-protective against p. aeruginosa serotypes
ES445768A1 (es) Metodo de preparacion de un reactivo en fase solida para usoen el radio inmunoensayo de antigenos y anticuerpos y de realizacon del radio inmunoensayo.
CA2025607A1 (en) Hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents
ATE50868T1 (de) Ultraschall-beschleunigte immuno-reaktionen.
NO965239L (no) Monoklonalt antistoff mot CD44v6
IT8820741A0 (it) Anticorpo monoclonale specifico per una sequenza di fibronettina espressa in cellule trasformate ibridoma secernente tale anticorpo e impiego dell'anticorpo monoclonale per la diagnosi di tumori.
FI932912A0 (fi) Testmetod och reagensfoerpackning avsedd foer den
ES444543A1 (es) Metodo de determinacion inmunologica.
GB1509707A (en) Immunological compounds
IT7828492A0 (it) Antigene per l'esame precoce di gravidanza e vaccino contraccettivo.
ES8404515A1 (es) Procedimiento de aglutinacion con latex para la deteccion o la determinacion de un participante en una reaccion inmunologica.
EP0245520A4 (de) Monoklonaler antikörper gegen glutathion s-transferase und dessen verwendung zur diagnose von krebs.
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
OA08782A (en) Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies.
IL55564A0 (en) Method for the quantitative determination of antigens in aqueous solutions
SU1163864A1 (ru) Способ определени антиэритроцитарных антител
SU601530A1 (ru) Вентил ционное устройство
ES498990A0 (es) Procedimiento para la determinacion inmunologica de anticuerpos, antigenos y haptenos por efecto comunicador de una ac- tividad enzimatica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties